Notch1 overexpression promotes cell growth and tumor angiogenesis in myeloma

Neoplasma

Volumn 60, Issue 1, 2013, Pages 33-40

  Guo, D ^a   Li, C ^a   Teng, Q ^a   Sun, Z ^a   Li, Y ^a   Zhang, C ^a  

^a Central Hospital of Taian   (China)

Author keywords

Angiogenesis; Myeloma; NOD SCID; Notch1; Vascular endothelial growth factor

Indexed keywords

BORTEZOMIB; NOTCH1 RECEPTOR; VASCULOTROPIN; NOTCH1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL CULTURE; CELL PROLIFERATION ASSAY; CELL VIABILITY; CONTROLLED STUDY; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; MYELOMA; NONHUMAN; PROTEIN EXPRESSION; RETROVIRUS INFECTION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; XENOGRAFT; ANIMAL; APOPTOSIS; CELL PROLIFERATION; ENZYME IMMUNOASSAY; METABOLISM; MOUSE MUTANT; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); NONOBESE DIABETIC MOUSE; PATHOLOGY; TUMOR CELL CULTURE; VASCULARIZATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED NOD; MICE, SCID; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, NOTCH1; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879025238     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_005     Document Type: Article

References (30)

1. ROTHENBERG EV. Negotiation of the T lineage fate decision by transcription-factor interplay and microenvironmental signals. Immunity. 2007, 26: 690-702. http://dx.doi.org/10.1016/j.immuni.2007.06.005
2. ARTAVANIS-TSAKONAS, RAND MD, LAKE RJ. Notch signaling: cell fate control and signal integration in development. Science. 30, 284: 770-776.
3. ISO T, KEDES L, HAMAMORI Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003, 194: 237-255. http://dx.doi.org/10.1002/jcp.10208
4. KAGEYAMA R, OHTSUKA T, HATAKEYAMA J, OHSAWA R. Roles of bHLH genes in neural stem cell differentiation. Exp Cell Res. 2005, 306: 343-348. http://dx.doi.org/10.1016/j.yexcr.2005.03.015
5. PANCEWICZ J, TAYLOR JM, DATTA A, BAYDOUN HH, WALDMANN TA, et al. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc Natl Acad Sci U S A. 2010, 107: 16619-16624. http://dx.doi.org/10.1073/pnas.1010722107
6. WEIJZEN S, RIZZO P, BRAID M, VAISHNAV R, JONKHEER SM, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med. 2002, 8: 979-986. http://dx.doi.org/10.1038/nm754
7. CHEN SM, LIU JP, ZHOU JX, CHEN C, DENG YQ, et al. Suppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation. Cancer Lett. 2011, 306: 76-84. http://dx.doi.org/10.1016/j.canlet.2011.02.034
8. HUGHES DP. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res. 2009, 152: 479-496. http://dx.doi.org/10.1007/978-1-4419-0284-9_28
9. GUO D, YE J, DAI J, LI L, CHEN F, et al. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res. 2009, 33: 678-685. http://dx.doi.org/10.1016/j.leukres.2008.10.026
10. HARRINGTON LS, SAINSON RC, WILLIAMS CK, TAYLOR JM, SHI W, et al. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvasc Res. 2008; 75, 144-154. http://dx.doi.org/10.1016/j.mvr.2007.06.006
11. SUCHTING S, FREITAS C, LE NOBLE F, BENEDITO R, BREANT C, et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A. 2007, 104: 3225-3230. http://dx.doi.org/10.1073/pnas.0611177104
12. SHAWBER CJ, FUNAHASHI Y, FRANCISCO E, VORONTCHIKHINA M, KITAMURA Y, et al. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest. 2007, 117: 3369-3382. http://dx.doi.org/10.1172/JCI24311
13. LI JL, HARRIS AL. Notch signalling from tumor cells: a new mechanism of angiogenesis. Cancer Cell. 2005, 8: 1-3. http://dx.doi.org/10.1016/j.ccr.2005.06.013
14. REHMAN AO, WANG CY. Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol. 2006, 16: 293-300. http://dx.doi.org/10.1016/j.tcb.2006.04.003
15. HU Y, NGUYEN TT, BUI KC, DEMELLO DE, SMITH JB. A novel inflammation-induced ubiquitin E3 ligase in alveolar type II cells. Biochem Biophys Res Commun. 2005, 333: 253-263. http://dx.doi.org/10.1016/j.bbrc.2005.05.102
16. MOUSSA O, RIKER JM, KLEIN J, FRAIG M, HALUSHKA PV, WATSON DK. Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents. Oncogene. 2008, 27: 55-62. http://dx.doi.org/10.1038/sj.onc.1210629
17. SKRTIC A, Korac P, KRISTO DR, AJDUKOVIC STOJISAVLJEVIC STOJISAVLJEVIC R, et al. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance. Hum Pathol. 2010, 41: 1702-1710. http://dx.doi.org/10.1016/j.humpath.2010.05.002
18. JUNDT F, PROBSTING KS, ANAGNOSTOPOULOS I, MUEHLINGHAUS G, CHATTERJEE M, et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood. 2004, 103: 3511-3515. http://dx.doi.org/10.1182/blood-2003-07-2254
19. ZWEIDLER-MCKAY PA, HE Y, XU L, RODRIGUEZ CG, KAMELL FG, et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood. 2005, 106: 3898-3906. http://dx.doi.org/10.1182/blood-2005-01-0355
20. NEFEDOVA Y, CHENG P, ALSINA M, DALTON WS, GABRILOVICH DI. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood. 2004, 103: 3503-3510. http://dx.doi.org/10.1182/blood-2003-07-2340
21. JUNDT F, ANAGNOSTOPOULOS I, FORSTER R, MATHAS S, STEIN H, et al. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002, 99: 3398-3403. http://dx.doi.org/10.1182/blood.V99.9.3398
22. NEFEDOVA Y, SULLIVAN DM, BOLICK SC, DALTON WS, GABRILOVICH DI. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood. 2008, 111: 2220-2229. http://dx.doi.org/10.1182/blood-2007-07-102632
23. WANG Z, LI Y, AHMAD A, AZMIL AS, BANERJEE S, et al. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta. 2010, 1806: 258-267.
24. GUO D, YE J, LI L, DAI J, MA D, et al. Down-regulation of Notch-1 increases co-cultured Jurkat cell sensitivity to chemotherapy. Leuk Lymphoma. 2009, 50: 270-278. http://dx.doi.org/10.1080/10428190802553257
25. ZANG S, CHEN F, DAI J, GUO D, TSE W, et al. RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer. Oncol Rep. 2010, 23: 893-899.
26. WANG H, LIU X, XU B. Proteasome inhibitor induces apoptosis and influences the expression of Notch1 and NF-kappaB in multiple myeloma RPMI8226 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008, 16: 531-537.
27. WANG Z, BANERJEE S, LI Y, RAHMAN KM, ZHANG Y, et al. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res. 2006, 66: 2778-2784. http://dx.doi.org/10.1158/0008-5472.CAN-05-4281
28. WANG Z, LI Y, BANERJEE S, KONG D, AHRMAD A, et al. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J Cell Biochem. 2010, 109: 726-736.
29. PODAR K, ANDERSON K. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implication. Blood. 2005, 105: 1383-1395. http://dx.doi.org/10.1182/blood-2004-07-2909
30. MARKOVIC O, MARISAVLJEVIC D, CEMERIIKIC V, VIDOVIC A, PERUNICIC M, et al. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance. Med Oncol. 2008, 25: 451-457. http://dx.doi.org/10.1007/s12032-008-9066-y